Garmany, Ramin
Bos, J. Martijn
Dasari, Surendra
Johnson, Kenneth L.
Tester, David J.
Giudicessi, John R.
dos Remedios, Cristobal
Maleszewski, Joseph J.
Ommen, Steve R.
Dearani, Joseph A.
Ackerman, Michael J.
Funding for this research was provided by:
Medical Scientist Training Program, Mayo Clinic
Louis V. Gerstner, Jr. Fund at Vanguard Charitable
Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program
Paul and Ruby Tsai and Family Hypertrophic Cardiomyopathy Research Fund
Medical Advances Without Animals Trust
Article History
Received: 1 June 2023
Accepted: 16 August 2023
First Online: 1 September 2023
Competing interests
: MJA is a consultant for Abbott, Boston Scientific, Bristol Myers Squibb, Daiichi Sankyo, Invitae, Medtronic, Tenaya Therapeutics, and UpToDate. MJA and Mayo Clinic have a royalty/equity relationship with AliveCor, Anumana, ARMGO Pharma, Pfizer, and Thryv Therapeutics. However, none of these entities have contributed to this study in any manner. The remaining authors have no conflicts to declare.